DR

David Ross

UC University of Colorado, A Body Corporate: 8 patents #27 of 1,219Top 3%
GL Grifols Worldwide Operations Limited: 8 patents #1 of 45Top 3%
UC University of Colorado: 2 patents #138 of 930Top 15%
UV University of Virginia: 2 patents #244 of 1,170Top 25%
IT Indiana University Research And Technology: 2 patents #131 of 664Top 20%
US University Of Salford: 1 patents #5 of 22Top 25%
📍 Cary, NC: #278 of 3,681 inventorsTop 8%
🗺 North Carolina: #2,125 of 45,564 inventorsTop 5%
Overall (All Time): #201,433 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
12280110 Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM Thomas Barnett 2025-04-22
RE50230 Method of treatment of hypoxia inducible factor (HIF)-related conditions Ralph Christian Crumine 2024-12-10
11964985 Anti-cancer compounds targeting Ral GTPases and methods of using the same Dan Theodorescu, Michael Fitzpatrick Wempe, Samy Meroueh, Martin A. Schwartz, Phillip Reigan 2024-04-23
11756068 Systems and methods for providing interaction with electronic billboards Nanxi Liu, David Wei Zhu, Zach Spitulski, Navdeep Reddy 2023-09-12
11472812 Anti-cancer compounds targeting Ral GTPases and methods of using the same Dan Theodorescu, Michael Fitzpatrick Wempe, Chao Yan, Phillip Reigan 2022-10-18
RE49129 Method of treatment of hypoxia inducible factor (HIF)-related conditions Ralph Christian Crumrine 2022-07-12
11208471 Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) Thomas Barnett 2021-12-28
RE48557 Anti-cancer compounds targeting Ral GTPases and methods of using the same Dan Theodorescu, Michael Fitzpatrick Wempe, Chao Yan, Phillip Reigan 2021-05-18
10689392 Anti-cancer compounds targeting ral GTPases and methods of using the same Dan Theodorescu, Michael Fitzpatrick Wempe, Samy Meroueh, Martin A. Schwartz, Phillip Reigan 2020-06-23
10676480 Anti-cancer compounds targeting Ral GTPases and methods of using the same Dan Theodorescu, Michael Fitzpatrick Wempe, Chao Yan, Phillip Reigan 2020-06-09
10660956 Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM Thomas Barnett 2020-05-26
10570194 Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) Thomas Barnett 2020-02-25
10214487 Indole derivatives and methods of using the same Philip Reigan, David Siegel, Christopher J. Moody, Marie A. Colucci, Donna Dehn 2019-02-26
10202397 Anti-cancer compounds targeting Ral GTPases and methods of using the same Dan Theodorescu, Michael Fitzpatrick Wempe, Chao Yan, Phillip Reigan 2019-02-12
9913903 Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM Thomas Barnett 2018-03-13
9687530 Method of treatment of Hypoxia Inducible Factor (HIF)-related conditions Ralph Christian Crumrine 2017-06-27
9603829 HSP90 inhibitors with modified toxicity David M. Siegal, Christopher J. Moody, Russell Richard Anthony Kitson 2017-03-28
9353121 Anti-cancer compounds targeting Ral GTPases and methods of using the same Dan Theodorescu, Michael Fitzpatrick Wempe, Samy Meroueh, Martin A. Schwartz, Phillip Reigan 2016-05-31
8551964 Hsp90 inhibitors with modified toxicity David Siegel, Wenchang Guo, Christopher J. Moody, Christopher S. P. McErlean 2013-10-08
7608611 Hsp90 inhibitors, methods of making and uses therefor David Siegel, Philip Reigan, Wenchang Guo, Daniel L. Gustafson 2009-10-27
6156744 DT-diaphorase directed anti-tumor agents John Butler, Robert H. J. Hargreaves, David Siegel, Howard D. Beall 2000-12-05